4D Molecular Therapeutics

Quick facts

Phase 2 pipeline

• 4D-710 · Cystic Fibrosis
  4D-710 is a gene therapy that uses an adeno-associated virus to deliver a functional copy of the CFTR gene to the lungs, correcting the underlying genetic defect in cystic fibrosis.
• Aflibercept IVT · Ophthalmology
  Aflibercept IVT is a vascular endothelial growth factor (VEGF) trap that binds and neutralizes VEGF and placental growth factor (PlGF) to inhibit pathological angiogenesis and vascular permeability.

Phase 1 pipeline

• 4D-110
• 4D-310

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• 4D Molecular Therapeutics portfolio CI brief
• 4D Molecular Therapeutics pipeline updates RSS